Literature DB >> 9927210

Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.

C Giamarchi1, M Solanas, C Chailleux, P Augereau, F Vignon, H Rochefort, H Richard-Foy.   

Abstract

We have compared the DNase I hypersensitivity of the regulatory region of two estrogen-regulated genes, pS2 and cathepsin D in hormone-dependent and -independent breast carcinoma cell lines. This strategy allowed the identification of two important control regions, one in pS2 and the other in cathepsin D genes. In the hormone-dependent MCF7 cell line, within the pS2 gene 5'-flanking region, we detected two major DNase I hypersensitive sites, induced by estrogens and/or IGFI: pS2-HS1, located in the proximal promoter and pS2-HS4, located -10.5 Kb from the CAP site, within a region that has not been cloned. The presence of these two DNase I hypersensitive sites correlates with pS2 expression. Interestingly in MCF7 cells, estrogens and IGFI induced indistinguishable chromatin structural changes over the pS2 regulatory region, suggesting that the two transduction-pathways converge to a unique chromatin target. In two cell lines that do not express pS2, MDA MB 231, a hormone-independent cell line that lacks the estrogen receptor alpha, and HE5, a cell line derived from MDA MB 231 by transfection that expresses estrogen receptor alpha, there was only one hormone-independent DNase I hypersensitive site. This site, pS2-HS2, was located immediately upstream of pS2-HS1. In MCF7 cells, two major DNase I hypersensitive sites were present in the 5'-flanking sequences of the cathepsin D gene, which is regulated by estrogens in these cells. These sites, catD-HS2 and catD-HS3, located at positions -2.3 Kb and -3.45 Kb, respectively, were both hormone-independent. A much weaker site, catD-HS1, covered the proximal promoter. In MDA MB 231 cells, that express cathepsin D constitutively, we detected an additional strong hormone-independent DNase I hypersensitive site, catD-HS4, located at position -4.3 Kb. This region might control the constitutive over-expression of cathepsin D in hormone-independent breast cancer cells. All together, these data demonstrate that a local reorganization of the chromatin structure over pS2 and cathepsin D promoters accompanies the establishment of the hormone-independent phenotype of the cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927210     DOI: 10.1038/sj.onc.1202317

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.

Authors:  Nobuhiro Ijichi; Takashi Shigekawa; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2012-04-03       Impact factor: 3.869

2.  Unexpected hormonal activity of a catechol equine estrogen metabolite reveals reversible glutathione conjugation.

Authors:  Kuan-Wei Peng; Minsun Chang; Yue-Ting Wang; Zhican Wang; Zhihui Qin; Judy L Bolton; Gregory R J Thatcher
Journal:  Chem Res Toxicol       Date:  2010-08-16       Impact factor: 3.739

3.  CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.

Authors:  Yu Zhang; Jing Liang; Yanyan Li; Chenghao Xuan; Feng Wang; Dandan Wang; Lei Shi; Di Zhang; Yongfeng Shang
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

Review 4.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

5.  FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.

Authors:  Takashi Shigekawa; Nobuhiro Ijichi; Kazuhiro Ikeda; Kuniko Horie-Inoue; Chikako Shimizu; Shigehira Saji; Kenjiro Aogi; Hitoshi Tsuda; Akihiko Osaki; Toshiaki Saeki; Satoshi Inoue
Journal:  Horm Cancer       Date:  2011-10       Impact factor: 3.869

6.  Hormone-induced modifications of the chromatin structure surrounding upstream regulatory regions conserved between the mouse and rabbit whey acidic protein genes.

Authors:  Benjamin Millot; Lluís Montoliu; Marie-Louise Fontaine; Teresa Mata; Eve Devinoy
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

7.  BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation.

Authors:  J DiRenzo; Y Shang; M Phelan; S Sif; M Myers; R Kingston; M Brown
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

Review 8.  The role of histone modifications and variants in regulating gene expression in breast cancer.

Authors:  Mathieu Dalvai; Kerstin Bystricky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-02-04       Impact factor: 2.673

9.  Interaction of the double-strand break repair kinase DNA-PK and estrogen receptor-alpha.

Authors:  Senad Medunjanin; Sönke Weinert; Alexander Schmeisser; Doris Mayer; Ruediger C Braun-Dullaeus
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

10.  A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene.

Authors:  Amandine Chatagnon; Esteban Ballestar; Manel Esteller; Robert Dante
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.